In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
- TRADE NAME: Seroquel (AstraZeneca)
- INDICATIONS: Schizophrenia, bipolar I disorder
- CLASS: Antipsychotic, Antipsychotic, atypical, Mood stabilizer
- HALF-LIFE: ~6 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, Amoxapine, Antihypertensive agents, Arsenic, Atazanavir, Azithromycin, CNS acting drugs, Darunavir, Dolasetron, Dopamine, Drugs known to cause electrolyte imbalance or increase QT interval, Erythromycin, Fluconazole, Hepatic enzyme inducers, Itraconazole, Ketoconazole, Levodopa, Methadone, P4503A inhibitors, Pazopanib, Telavancin, Tipranavir, Tricyclic antidepressants, Voriconazole
- See adverse reactions attributed to class:
Elderly patients with dementia-related psychosis treated
with antipsychotic drugs are at an increased risk of death.
Quetiapine is not approved for the treatment of patients with dementia-related psychosis.
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warnings.
Please login to view the rest of this drug profile.
Page last updated 02/24/2025
